tiprankstipranks
Mural Oncology ‘undervalued,’ initiated with Strong Buy at Raymond James
PremiumThe FlyMural Oncology ‘undervalued,’ initiated with Strong Buy at Raymond James
2M ago
Premium
Company Announcements
Mural Oncology’s Investor Day Highlights Cancer Treatment Trials
2M ago
Mural Oncology provides update on ARTISTRY-7 at Investor Day
Premium
The Fly
Mural Oncology provides update on ARTISTRY-7 at Investor Day
2M ago
Mural Oncology appoints Sachiyo Minegishi to board of directors
PremiumThe FlyMural Oncology appoints Sachiyo Minegishi to board of directors
2M ago
Mural Oncology to host first virtual Investor Day on September 26
Premium
The Fly
Mural Oncology to host first virtual Investor Day on September 26
2M ago
Mural Oncology reports Q2 EPS ($1.86) vs ($3.01) last year
Premium
The Fly
Mural Oncology reports Q2 EPS ($1.86) vs ($3.01) last year
3M ago
Mural Oncology presents clinical data from Artistry-3 at ASCO
PremiumThe FlyMural Oncology presents clinical data from Artistry-3 at ASCO
6M ago
Seven new option listings on May 15th
Premium
The Fly
Seven new option listings on May 15th
6M ago
Mural Oncology expects cash to fund operations into Q4 of 2025
Premium
The Fly
Mural Oncology expects cash to fund operations into Q4 of 2025
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100